• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Funding - Articles and news items

NHS England to fund bionic eye surgery

Industry news / 3 January 2017 / Niamh Louise Marriott, Digital Editor

Surgeons at Manchester and Moorfields Eye Hospital made history by delivering the world’s first trial of the Argus II Bionic Eye implants in RP…

Takeda makes €10 million equity investment in TiGenix

Industry news / 22 December 2016 / Niamh Louise Marriott, Digital Editor

TiGenix, has exercised the option granted by Takeda under the licensing agreement to make a €10 million equity investment in TiGenix…

Trial uses herpes drugs to slow down Alzheimer’s disease

Industry news / 20 December 2016 / Niamh Louise Marriott, Digital Editor

The first clinical study to investigate if herpes virus drugs can have an effect on fundamental Alzheimer’s disease processes has been launched…

Bellicum recommended for $16.9 million Texan cancer research award

Industry news / 22 November 2016 / Niamh Louise Marriott, Digital Content Producer

The Institute of Texas award would fund a 3 year global clinical program of clinical trials for adult and paediatric patients acute myeloid leukaemia…

F is for Funding

Blog / 21 November 2016 / Niamh Louise Marriott, Digital Content Producer

F is for Funding – the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest grants and funds…

Mucosis’ needle-free nasal spray vaccine for RSV trial starts

Industry news / 8 November 2016 / Niamh Louise Marriott, Digital Content Producer

Mucosis has begun a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London…

Post-meal hyperglycaemia has negative impact on diabetic quality of life

Industry news / 4 November 2016 / Niamh Louise Marriott, Digital Content Producer

New data from a study related to post-meal or postprandial glucose control, show that poor PPG control has a negative impact on diabetics quality of life…

Verastem licenses Duvelisib from Infinity Pharmaceuticals for $28 million

Industry news / 3 November 2016 / Niamh Louise Marriott, Digital Content Producer

Verastem licensed exclusive worldwide rights to develop and commercialise Infinity’s oncology product candidate duvelisib…

MicuRx’S Phase III MRSA antibiotic trial to support Chinese NDA filing

Industry news / 20 October 2016 / Niamh Louise Marriott, Digital Content Producer

The recent $55M Series C financing will allow MicuRx to complete this Phase 3 study, and at a vital time with antibiotic resistance at an all time high…

big pharma

How Big Pharma’s money is affecting our health and our wallets

Blog, Z Homepage promo / 17 October 2016 / Rebecca Hill, TheLawFirm.com

Read Injury Lawyer Rebecca Hill’s review on how Big Pharma’s money is affecting our health and our wallets and the suggestions for change…

head and neck cancer

‘Game-changing’ immunotherapy doubles head and neck cancer survival

Industry news, Z Homepage promo / 10 October 2016 / Niamh Louise Marriott, Digital Content Producer

An immunotherapy drug has been hailed as a ‘game changer’ after being found to greatly improve survival for patients with relapsed head and neck cancer…

NICE recommends first drug for the Cancer Drugs Fund

Industry news / 4 October 2016 / Niamh Louise Marriott, Digital Content Producer

Osimertinib is the first new cancer drug to be introduced into the NHS under a Cancer Drugs Fund managed access agreement…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +